Feature Channels:

Autoimmune Diseases

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 29-Mar-2017 4:00 PM EDT

Medicine

Channels:

Seth Margolis, Alzheimer’s, ephexin5 , Brain, Amyloid

Protein That Regulates Brain Cell Connections Could Be New Target for Treating Alzheimer's Disease

neuronssynapselighted_iStock-92039119.jpg

In experiments with a protein called Ephexin5 that appears to be elevated in the brain cells of Alzheimer's disease patients and mouse models of the disease, Johns Hopkins researchers say removing it prevents animals from developing Alzheimer's characteristic memory losses. In a report on the studies, published online March 27 in The Journal of Clinical Investigation, the researchers say the findings could eventually advance development of drugs that target Ephexin5 to prevent or treat symptoms of the disorder.

Medicine

Channels:

Aarda, Autoimmune, ACA, Trump, Congress, Funding, Healthcare, Survey Research

In New AARDA Survey, Autoimmune Disease Patients Voice Top Concerns, Priorities to President Trump and Federal and State Legislators

AARDA-25thanniversarylogo.jpg

WASHINGTON, DC, MARCH 28, 2017 – With the intense focus of the Trump Administration and Republican leadership in Congress on repealing and replacing the Affordable Care Act (ACA) since the inauguration, a survey conducted by the American Autoimmune Related Diseases Association (AARDA) finds that the vast majority of autoimmune disease patients do not believe that U.S. elected officials, including President Trump as well as other Federal and State elected officials, understand that autoimmunity is a major U.S. health issue. In addition, they voice apprehension over the future of health insurance and what it means for their care, and believe that legislation must be in place to prevent insurance companies from taking medical decisions away from patients’ doctors.

Medicine

Channels:

Alzheimber's Disease, Dementia

Gene Discovered Associated with Tau Pathology

Investigators at Rush University Medical Center and the Brigham and Women’s Hospital in Boston reported the discovery of a new gene that is associated with susceptibility to a common form of brain pathology called Tau that accumulates in several different conditions, including Alzheimer’s disease, certain forms of dementia and Parkinsonian syndromes as well as chronic traumatic encephalopathy that occurs with repeated head injuries.

Medicine

Science

Channels:

Weight-Bearing Exercises, Bariatric Surgery and Joints, A New Metabolic Pathway, and More in the Obesity News Source

Click here to go directly to Newswise's Obesity News Source

Medicine

Channels:

California Researchers Awarded $100,000 Potamkin Prize for Dementia Research

The American Academy of Neurology is awarding two California researchers the 2017 Potamkin Prize for Research in Pick’s, Alzheimer’s and Related Diseases for their work in dementia research. Claudia Kawas, MD, of the University of California, Irvine, and Kristine Yaffe, MD, of the University of California, San Francisco, both members of the American Academy of Neurology, will be honored at the American Academy of Neurology’s 69th Annual Meeting in Boston.

Science

Channels:

Alzheimber's Disease, Neurochemistry

Researchers Focus on Cell Membranes to Develop Alzheimer's Treatments

Thin parts of the cell membranes of neurons turn out to be particularly vulnerable to a protein that collects in the brain of people with Alzheimer's disease, according to a University of Michigan researcher.

Medicine

Channels:

Early Infant Weight Gain, Preventing Vision Loss, Sesame Street's Julia, and More in the Children's Health News Source

Click here for the latest research and features on Children's Health.

Medicine

Channels:

Alzheimber's Disease, Genetics, Neurology, Epidemiology, genetic assessment, polygenic hazard score

Genetic Assessment Developed to Determine Risk for Age-Associated Alzheimer’s Disease

An international team of scientists, led by researchers at University of California San Diego School of Medicine and University of California San Francisco, has developed a novel genetic score that allows individuals to calculate their age-specific risk of developing Alzheimer’s disease (AD), based upon genetic information.

Medicine

Channels:

Tea, Aging, Ageing, neurocognitive disorders, Cohort Study

NUS Study: Daily Consumption of Tea Protects the Elderly From Cognitive Decline

2017-0316-teacognitivedecline.jpg

A study led by Assistant Professor Feng Lei from National University of Singapore’s Yong Loo Lin School of Medicine has found that regular consumption of tea lowers the risk of cognitive decline in the elderly, and this is especially so for APOE e4 gene carriers who are genetically at risk of developing Alzheimer’s disease.







Chat now!